![Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology: Molecular Therapy Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology: Molecular Therapy](https://www.cell.com/cms/attachment/f1e5e404-bbcf-4b1c-973f-cfd7765056c3/gr1_lrg.jpg)
Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology: Molecular Therapy
![The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates | npj Vaccines The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates | npj Vaccines](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41541-020-0191-8/MediaObjects/41541_2020_191_Fig4_HTML.png)
The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates | npj Vaccines
Taxonomic notes and distribution extension of Durga Das's leaf-nosed bat Hipposideros durgadasi Khajuria, 1970 (Chiroptera: Hipposideridae) from south India
![Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology: Molecular Therapy Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology: Molecular Therapy](https://www.cell.com/cms/attachment/1a3dce4e-6f49-4838-8843-4f33cf833895/gr4.jpg)
Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology: Molecular Therapy
![The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates | npj Vaccines The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates | npj Vaccines](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41541-020-0191-8/MediaObjects/41541_2020_191_Fig1_HTML.png)
The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates | npj Vaccines
![Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology: Molecular Therapy Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology: Molecular Therapy](https://www.cell.com/cms/attachment/d20dd3ee-b1ca-4c49-b76d-5d0a1b5f1998/gr3.jpg)
Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology: Molecular Therapy
![The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates | npj Vaccines The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates | npj Vaccines](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41541-020-0191-8/MediaObjects/41541_2020_191_Fig2_HTML.png)
The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates | npj Vaccines
![Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology: Molecular Therapy Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology: Molecular Therapy](https://www.cell.com/cms/attachment/6dd7f412-df91-4b42-b560-cb63d8c36334/gr2.jpg)